Parsaclisib Under Review for Follicular, Marginal Zone, and Mantle Cell Lymphomas
The application is supported by data from several phase 2 studies.
Diagnosis & Disease Information
Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
Lymphoma Patients Show Continued Cognitive Decline After Chemotherapy
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Study Finds Association Between Hypertension and Ibrutinib Treatment
Researchers defined the association between blood pressure and ibrutinib compared with chemoimmunotherapy in patients with B cell malignancies.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
- Loading...
Loading...
Next post in News
Loading... 
Loading...